Dr. Elizabeth Y. Chiao, MD

Dr. Chiao practices at Harris Health Ben Taub Hospital in Houston, Texas, part of Harris County, TX.

Dr. Chiao's NPI, 1013097443, was assigned on October 17, 2006. Dr. Chiao graduated from Weill Cornell Medicine in 1998. Dr. Chiao holds Texas license L8647.

Dr. Chiao's primary practice is Harris Health Ben Taub Hospital, at 1504 Taub Loop, Houston, TX 77030 in Harris County. The practice phone is (713) 873-2000.

Dr. Chiao's primary practice is Harris Health Ben Taub Hospital in Houston, Texas, part of Harris County, TX. The medical group on file is Physicians Referral Service. Dmand AI also links Dr. Chiao to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chiao practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Chiao's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Chiao is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Chiao's licenses on file in 12 states: Texas, Florida, Washington, Alabama, Arizona, Georgia, Louisiana, Mississippi, Oklahoma, Tennessee, New York and Utah.

CMS data shows 23 Medicare services from Dr. Chiao across 1 procedure code in 2024, all of them office visits, for 15 Medicare patients. Medicare paid $1,586 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 15 Medicare patients who saw Dr. Chiao in 2024. 75% of them have high cholesterol. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chiao's median patient age at 54, with 14% women.

In 2024, Dr. Chiao wrote 112 Medicare Part D claims for 26 patients. 88% of them were for generic drugs. CMS names the drug for 27 of them, across 2 drugs with 11 or more claims each, at $107 in total drug cost. In 2023, CMS named 46 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Chiao for performance year 2024, reported as part of a group. Dr. Chiao accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 192 papers to Dr. Chiao, published from 2006 to 2025. 2023 was the busiest year, with 18. The most frequent topics are HIV Infections, Anus Neoplasms and Papillomavirus Infections. Dr. Chiao has published most often in Clin Infect Dis. Dr. Chiao's most frequent co-authors are Thomas P. Giordano, MD, Elizabeth A. Stier, MD and Kathleen M. Schmeler, MD.

Dmand AI links Dr. Chiao to 8 clinical trials, 3 of them phase 1/2 studies. Conditions studied include AIDS-related Kaposi sarcoma, Sarcoma, Kaposi and Multi-centric Castleman's Disease. AIDS Malignancy Consortium sponsors the most, 4.

CMS Open Payments shows 12 general payments to Dr. Chiao from 4 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $209.

Dr. Chiao graduated from Weill Cornell Medicine in 1998.

Dr. Chiao is in network with 14 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.